Abstract
The usefulness of lincomycin hydrochloride (LCM) in the treatment of otorhinolaryngological anaerobic infections was assessed.
1. LCM was administered to 25 patients including one infant: 7 with sinusitis, 7 with peritonsillar abscess, 2 with congenital preaural fistula, 2 with buccal cyst, 2 with gingival abscess, 1 with infection of a cervical tumor, 1 with parotid gland abscess, 1 with a cyst of the vestibule of the nose, 1 with acute parotitis and 1 with a submandibular cyst.
2. LCM was administered intramusculary (300-600mg) or by intravenous drip infusion (600mg), 2 or 3 times daily for at least 3 days.
3. LCM was clinically effective in 92% of the patients.
4. It was bacteriologically effective in 96%.
5. No side effects were noted.
6. LCM was confirmed to be a very useful drug for treating anaerobic otorhinolaryngological infections.
